These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 18798556

  • 1. Epidemiology and clinical risk factors predisposing to thromboembolism in children with cancer.
    Athale U, Siciliano S, Thabane L, Pai N, Cox S, Lathia A, Khan A, Armstrong A, Chan AK.
    Pediatr Blood Cancer; 2008 Dec; 51(6):792-7. PubMed ID: 18798556
    [Abstract] [Full Text] [Related]

  • 2. Thromboembolism in children with sarcoma.
    Athale U, Cox S, Siciliano S, Chan AK.
    Pediatr Blood Cancer; 2007 Aug; 49(2):171-6. PubMed ID: 16991135
    [Abstract] [Full Text] [Related]

  • 3. Thromboembolism in children with lymphoma.
    Athale UH, Nagel K, Khan AA, Chan AK.
    Thromb Res; 2008 Aug; 122(4):459-65. PubMed ID: 18237767
    [Abstract] [Full Text] [Related]

  • 4. Central venous line dysfunction is an independent predictor of poor survival in children with cancer.
    Athale UH, Siciliano S, Cheng J, Thabane L, Chan AK.
    J Pediatr Hematol Oncol; 2012 Apr; 34(3):188-93. PubMed ID: 22278202
    [Abstract] [Full Text] [Related]

  • 5. Central venous lines in children with lesser risk acute lymphoblastic leukemia: optimal type and timing of placement.
    McLean TW, Fisher CJ, Snively BM, Chauvenet AR.
    J Clin Oncol; 2005 May 01; 23(13):3024-9. PubMed ID: 15860859
    [Abstract] [Full Text] [Related]

  • 6. Thromboembolism in children with acute lymphoblastic leukaemia treated on Dana-Farber Cancer Institute protocols: effect of age and risk stratification of disease.
    Athale UH, Siciliano SA, Crowther M, Barr RD, Chan AK.
    Br J Haematol; 2005 Jun 01; 129(6):803-10. PubMed ID: 15953008
    [Abstract] [Full Text] [Related]

  • 7. Thromboembolic complications in pediatric hematologic malignancies.
    Athale UH, Chan AK.
    Semin Thromb Hemost; 2007 Jun 01; 33(4):416-26. PubMed ID: 17525899
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Thromboembolism in hospitalized neutropenic cancer patients.
    Khorana AA, Francis CW, Culakova E, Fisher RI, Kuderer NM, Lyman GH.
    J Clin Oncol; 2006 Jan 20; 24(3):484-90. PubMed ID: 16421425
    [Abstract] [Full Text] [Related]

  • 10. Comparison of low-molecular-weight heparin and antithrombin versus antithrombin alone for the prevention of symptomatic venous thromboembolism in children with acute lymphoblastic leukemia.
    Meister B, Kropshofer G, Klein-Franke A, Strasak AM, Hager J, Streif W.
    Pediatr Blood Cancer; 2008 Feb 20; 50(2):298-303. PubMed ID: 17443678
    [Abstract] [Full Text] [Related]

  • 11. A prospective cohort study determining the prevalence of thrombotic events in children with acute lymphoblastic leukemia and a central venous line who are treated with L-asparaginase: results of the Prophylactic Antithrombin Replacement in Kids with Acute Lymphoblastic Leukemia Treated with Asparaginase (PARKAA) Study.
    Mitchell LG, Andrew M, Hanna K, Abshire T, Halton J, Anderson R, Cherrick I, Desai S, Mahoney D, McCuster P, Wu J, Dahl G, Chait P, de Veber G, Lee KJ, Mikulis D, Ginsberg J, Way C, Prophylactic Antithrombin Replacement in Kids with Acute Lymphoblastic Leukemia Treated with Asparaginase Group (PARKAA).
    Cancer; 2003 Jan 15; 97(2):508-16. PubMed ID: 12518376
    [Abstract] [Full Text] [Related]

  • 12. Significant association with location of central venous line placement and risk of venous thrombosis in children.
    Male C, Julian JA, Massicotte P, Gent M, Mitchell L, PROTEKT Study Group.
    Thromb Haemost; 2005 Sep 15; 94(3):516-21. PubMed ID: 16268465
    [Abstract] [Full Text] [Related]

  • 13. Features at presentation predict children with acute lymphoblastic leukemia at low risk for tumor lysis syndrome.
    Truong TH, Beyene J, Hitzler J, Abla O, Maloney AM, Weitzman S, Sung L.
    Cancer; 2007 Oct 15; 110(8):1832-9. PubMed ID: 17724682
    [Abstract] [Full Text] [Related]

  • 14. Symptomatic venous thromboembolism in acute leukemia. Incidence, risk factors, and impact on prognosis.
    Ziegler S, Sperr WR, Knöbl P, Lehr S, Weltermann A, Jäger U, Valent P, Lechner K.
    Thromb Res; 2005 Oct 15; 115(1-2):59-64. PubMed ID: 15567454
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The risk for thromboembolic disease in lupus anticoagulant patients due to pathways involving P-selectin and CD154.
    Bugert P, Pabinger I, Stamer K, Vormittag R, Skeate RC, Wahi MM, Panzer S.
    Thromb Haemost; 2007 Apr 15; 97(4):573-80. PubMed ID: 17393020
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Hypophosphatemia in critically ill children: prevalence and associated risk factors.
    Santana e Meneses JF, Leite HP, de Carvalho WB, Lopes E.
    Pediatr Crit Care Med; 2009 Mar 15; 10(2):234-8. PubMed ID: 19057439
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Metabolic syndrome in Portugal: prevalence and implications for cardiovascular risk--results from the VALSIM Study.
    Fiuza M, Cortez-Dias N, Martins S, Belo A, VALSIM study investigators.
    Rev Port Cardiol; 2008 Dec 15; 27(12):1495-529. PubMed ID: 19280993
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.